Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection

Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection

Singapore Medical Journal

Saved in:

Bibliographic Details
Main Authors:	Chang, S.K.Y., Hlaing, W.W., Yu, R.Q., Lee, T.W.V., Ganpathi, I.S., Madhavan, K.K.
Other Authors:	OFFICE OF THE DEPUTY PRESIDENT(RES&TECH)
Format:	Article
Published:	2014
Subjects:	Alpha-foetoprotein Hepatocellular carcinoma Recurrence Screening
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/114724
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

PROTEOMICS IDENTIFICATION AND CHARACTERIZATION OF NOVEL BIOMARKERS ASSOCIATED WITH RECURRENCE OF HEPATOCELLULAR CARCINOMA
by: LEE SEOW CHONG
Published: (2016)

Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
by: Guo, Yuxin, et al.
Published: (2023)

Resection for hepatocellular carcinoma: Is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?
by: Chow, P.K.-H.
Published: (2014)

Re: Alpha-foetoprotein: An inaccurate test for survei l lance of post - treatment recurrence of hepatocellular carcinoma
by: Yong, S.C.K.
Published: (2016)

OVEREXPRESSION OF TYRO3 AND ITS IMPLICATION ON HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
by: DUAN YAN
Published: (2011)

Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis
by: Quek, Jingxuan, et al.
Published: (2023)

CCAAT/Enhancer binding protein alpha Knock-in mice exhibit early Liver glycogen storage, reduced susceptibility to hepatocellular carcinoma and increased hepatocyte functions
by: TAN EE HONG
Published: (2011)

Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: Review of 1222 cases of hepatectomy in a tertiary institution
by: Chieh Kow, A.W, et al.
Published: (2020)

Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023)

DERIVATION OF NOVEL CELLULAR MODELS OF HEPATOCELLULAR CARCINOMA
by: WANG SIYU
Published: (2019)

Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma
by: Burgmans, M.C., et al.
Published: (2014)

Circulating markers for prognosis of hepatocellular carcinoma
by: Wong, K.-F., et al.
Published: (2014)

Utilizing experimental mouse model to identify effectors of hepatocellular carcinoma induced by HBx antigen
by: Yang, M.-H., et al.
Published: (2021)

First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
by: Fong K.Y., et al.
Published: (2022)

Combined hepatocellular-cholangiocarcinoma: Diagnostic challenge in hepatic fine needle aspiration biopsy
by: Wee, A., et al.
Published: (2012)

Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant.
by: Guo, Yuxin, et al.
Published: (2023)

Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
by: Chong, Yong Chun, et al.
Published: (2020)

Prognosis prediction of hepatocellular carcinoma based on magnetic resonance imaging features
by: Low, Hsien Min, et al.
Published: (2023)

Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma
by: Goh, B.K.P., et al.
Published: (2016)

Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring
by: Hennedige, T., et al.
Published: (2016)

Diabetes mellitus and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study
by: Koh, W.-P., et al.
Published: (2014)

Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics
by: Wee, A.
Published: (2012)

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
by: Xiong, Zhewen, et al.
Published: (2023)

Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma
by: Poh, W., et al.
Published: (2014)

ABERRANT DNA METHYLATION IN HEPATOCELLULAR CARCINOMA
by: MAH WAY CHAMP
Published: (2014)

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma
by: Liu, Z.-M., et al.
Published: (2011)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2014)

p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection
by: Wee, A., et al.
Published: (2012)

p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection
by: Wee, A., et al.
Published: (2016)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

Validation of plasma membrane proteins expressed in invading hepatocellular carcinoma
by: Patamaporn Molee, et al.
Published: (2015)

Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma
by: Nissom, P.M., et al.
Published: (2011)

Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma
by: Nissom, P.M., et al.
Published: (2014)

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
by: Chow, Pierce K.H., et al.
Published: (2024)

DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA
by: CHERYLETTE ANNE ALEXANDER
Published: (2023)

Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions: Can they be distinguished on fine needle aspiration biopsy?
by: Wee, A., et al.
Published: (2012)

Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions: Can they be distinguished on fine needle aspiration biopsy?
by: Wee, A., et al.
Published: (2016)

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
by: Tenen, Daniel G., et al.
Published: (2022)

Up-regulation of C/EBPa in hepatocellular carcinoma is correlated to poorer prognosis
by: ANG YANG HUEY JESSICA
Published: (2013)

Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
by: Grinchuk, O.V., et al.
Published: (2022)